Company
NetherlandsPublic company, NYSE: ABTAbbott Laboratories B.V. (NYSE: ABT), Zwolle, Netherlands – FDA Inspections
Inspection records and compliance data for Abbott Laboratories B.V. in Zwolle. 1 FDA inspection on record, last inspected July 16, 2025. Publicly traded as NYSE: ABT.
Company Profile
This profile covers Abbott Laboratories B.V. based in Zwolle, Netherlands.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected July 16, 2025.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 16, 2025 | NAI | Foods & Cosmetics · Foodborne Biological Hazards | 1277377 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Abbott Laboratories B.V.
Stock ticker
ABT
Exchange
NYSE
Share price
$113.74
Market cap
$197.0B
Price as of
November 6, 2026
FEI Number
3009063263
Address
Rieteweg 21, Zwolle, Netherlands
Country
Netherlands
ID: 623d9026-0551-4385-afd2-828cc0da6c33